Cofounder and Chief Commercial Officer
Jeremy Carter, a veteran in the life sciences industry with over two decades of experience, has guided high-performance teams across sales and delivery functions globally, including in North America, Europe, Latin America, and Asia-Pacific. Known for his expertise in digital transformation, Carter’s strategic vision has enabled healthcare organizations to adopt forward-thinking approaches, such as the integration of AI in clinical trials and automation in compliance reporting. He also has a proven track record as a visionary go-to-market leader in the Life Science & MedTech sectors, driving cross-functional commercial strategies, market-shaping innovations, and accelerated growth across complex, regulated environments.
LinkedIn
Featured in top journals for innovative solutions bridging technology and commercial excellence
Cambridge, MA- Disrupting the healthcare Consulting landscape, Improzo Inc. is rapidly gaining traction with its innovative approach that tackles modern challenges and prioritizes patients.
Founded with a Mission- Born from the desire to improve patient access by addressing rising healthcare costs, Improzo partners with pharmaceutical and Medical device Companies.
The firm’s ability to navigate complex regulatory environments, combined with its focus on leveraging technology for greater efficiency, positions it as a valuable partner for organizations seeking to thrive in a competitive market.
Through its work with leading pharmaceutical companies & medical devices, Improzo uniquely blends the power of combining deep industry expertise with cutting-edge tools
The founders of Improzo Inc., Jeremy Carter and Abhishek Trigunait, bring exceptional expertise and leadership to the firm. Carter, a veteran in the life sciences industry with over two decades of experience, has guided high-performance teams across sales and delivery functions globally, including in North America, Europe, Latin America, and Asia-Pacific.